Pawar Law Group Announces That a Securities Class Action Lawsuit Has Been Filed Against Novo Nordisk A/S
The Pawar Law Group announces a class action lawsuit on behalf of Novo Nordisk A/S. (“Novo Nordisk” or the “Company”) (NVO) investors who purchased Novo Nordisk between April 30, 2015 and October 27, 2016, inclusive (the “Class Period”). The suit is for recovery of investor losses.